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Summary Mothers of a population-based series of 86 children with osteosarcoma or chondrosarcoma were
traced and their health status or cause of death ascertained. There were 6 cases of breast cancer among these
mothers and 6 other cancers. Risk of breast cancer was approximately three times that expected, and
appeared to be highest in mothers of boys and in mothers of children under the median age at diagnosis. The
mothers who developed breast cancer were relatively young at diagnosis compared with population data. Risk
of other malignancies in the mothers was not in excess of expectation. These findings are in line with those
reported for breast cancer risk in mothers of children with soft tissue sarcomas, and provide further
indications of a genetic component in the aetiology of these cancers.
Mothers of a population-based series of children
with soft tissue sarcomas have been shown to have
a three-fold excess risk of breast cancer compared
with women in the general population (Birch et al.,
1984). It is probable that a large proportion of
these families have a substantial genetic element
contributing to the development of cancers in their
members and that some of them may be examples
of the cancer family syndrome described by Li and
Fraumeni (1969). In an extended kindred of this
type (Lynch, 1978), three members developed
osteosarcoma at ages 8, 10 and 46 years. Other
malignancies occurring in this family were soft
tissue sarcomas, brain tumours, adrenal cortical
carcinoma and acute leukaemia. Breast cancer de-
veloped at the unusually early ages of 23, 29, 37
and 41 in four female relatives. In a similar pedi-
gree described by Blattner et al., (1979), early onset
breast cancer was also a notable feature. In view of
these observations and the findings of increased risk
of breast cancer in the soft tissue sarcoma mothers,
a study has been carried out to explore the risk of
breast cancer and other cancers in the mothers of
children with osteosarcoma and chondrosarcoma,
and to determine whether any specific high risk
groups of mothers could be defined in relation to
clinical features of the child at the time of
diagnosis.
Methods
The histology slides of all possible cases of primary
bone tumours in children under the age of fifteen
years in the Manchester Children's Tumour Regis-
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try (MCTR), who were diagnosed between January
1st, 1954 and December 31st, 1983, were reviewed
in order to determine those cases of osteosarcoma
and chondrosarcoma to be included in the study.
The MCTR is described in detail by Birch et al.
(1980), and ascertainment of cases has been es-
timated to be 95-99% complete (Leck et al., 1976).
For each child included in the study the case
records were abstracted with reference to the fol-
lowing: sex, age at diagnosis, and site of primary
tumour. Median age at diagnosis was calculated.
The current general practitioners (GPs) of the
mothers of all the children in the study were then
identified' with the help of Family Practitioner
Committees, the National Health Service Central
Register and other local sources. These methods
have been described by Birch et al. (1984). A
questionnaire asking about previous neoplastic
disease and other chronic illness in the mother was
then sent to each GP. A search for the mothers'
names in the records of the North West Regional
Cancer Register was also made. Causes of death
were ascertained from medical records or from
death notifications. If the mother had suffered from
malignant disease, the hospital case notes were
abstracted and, where still available, the histology
slides were obtained and reviewed.
The cumulative risks with age of breast cancer
and other cancers were estimated, using population
data for the North West Region (North Western
Regional Health Authority, 1982). These were used
to calculate the expected numbers of cancers among
this group of mothers, taking into account their age
at last follow-up by their GP, or age at death as
appropriate. Observed and expected numbers of
cancers among the mothers were compared and
significance tests carried out using the method
described by Rothman and Boice (1982) for exact
testing and estimation for a Poisson variate.
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Results
After histological review, there were 85 cases
eligible for the study, 75 osteosarcomas and 10
chondrosarcomas. In addition there was one child
for whom no histology was available, but where the
clinical and radiological evidence was felt to be
sufficiently firm for a diagnosis of osteosarcoma to
be made. There was a slight excess of girls among
the osteosarcomas (Table I). Median age at diag-
nosis for all cases combined was 12 years 3 months.
The majority of tumours occurred in the long
bones, with 50% having primary sites in the femur.
The second most common site was the tibia, fol-
lowed by the humerus. Other rarer sites include the
fibula, ulna, skull, spine and pelvis, clavicle and
calcaneus. One extra-osseus tumour was included in
the series, an osteosarcoma occurring in the brain.
Two children in the series had had previous malig-
nancies, a boy with bilateral retinoblastoma at the
age of 4 months, and a girl with a medulloblastoma
age 3 years.
Of the 86 cases of osteosarcoma or chondro-
sarcoma, 2 were adopted and so no further infor-
mation about their mothers was available, and one
child had a double primary tumour. There were no
sib pairs amongst the cases. Hence there were 83
mothers eligible for inclusion in the study, all of
whom were successfully traced or for whom a cause
of death was ascertained. The median age at
follow-up or death for all mothers was 56 years
(interquartile range 45-62 years). Eight mothers in
the series had died from causes other than cancer at
ages ranging from 34 to 73 years: four from
cardiovascular disease and one each from: per-
forated peptic ulcer, tuberculosis, broncho-
pneumonia, and aspiration of vomit as a result of
gastritis. There were 6 cases of breast cancer in the
remaining mothers and 6 neoplasms of other sites.
Histological material was available for all of the
breast cancers and 4 of the other neoplasms, and
was subject to special review for the study.
Table II summarises the features of the breast
cancers in the mothers in relation to the age, sex
and histology of the tumours in their respective
children. All the breast cancers were unilateral and
age at diagnosis ranged from 27 to 54 years.
Information on menopausal status at time of diag-
nosis of breast cancer was available for only three
of the mothers. As it is probable that the other
three mothers were pre-menopausal, it appears that
only one was post-menopausal at the time of
diagnosis.
Five of the 6 mothers are still alive, the period of
survival ranging from 1 to 24 years, the only
mother to have died being the one whose cancer
was diagnosed at the age of 27 years.
Table I Index child. Distribution of primary sites and
histology.
Males Females Totals
Osteosarcoma
Long bones:
Femur 14 25 39
Tibia 5 9 14
Fibula 3 0 3
Humerus 7 4 11
Ulna 1 0 1
Other sites:
Skull 0 1 1
Pelvis 2 1 3
Clavicle 0 2 2
Calcaneus 1 0 1
Extra-osseous (brain) 1 0 1
Total 34 42 76
Chondrosarcoma
Long bones:
Femur 2 2 4
Tibia 0 1 l
Fibula 1 0 1
Humerus 0 2 2
Other sites:
Spine 1 0 1
Pelvis 1 0 1
Total 5 5 10
Table III shows the expected and observed num-
bers of breast cancers in all the mothers, together
with those for various subgroups of mothers de-
fined according to the sex, age at diagnosis and site
of the tumour in their children. For all mothers
combined there was a 2.9-fold excess risk of devel-
oping breast cancer (P=0.012). The excess risk
appeared to be highest in mothers of boys
(RR=4.4; P=0.008), and in mothers of children
under the median age at diagnosis (RR =4.5;
P=0.008). However, because of the small numbers
in each subgroup these findings should be inter-
preted with caution. Site of the tumour in the child
did not appear to influence risk of breast cancer.
Features of the other neoplasms are shown in
Table IV. Age at diagnosis ranged from 31 to 68
years. The number of these other neoplasms in the
mothers did not differ significantly from expec-
tation, with 6 observed and 4.9 expected and,
although mothers of girls might appear to be at
higher risk, this was not statistically significant.
Discussion
This study indicates that mothers of children withBREAST CANCER RISK 821
Table II Breast cancers in mothers.
Mother Child
Age at Age at
diagnosis Menopausal diagnosis
Histology Site (yrs) status Histology Site (yrs) Sex
Infiltrating ducta R 27 NR Osteosarcoma L occipito- 8 F
parietal
region skull
Intraduct carcinomaa L 40 NR Osteosarcoma R femur 10 M
Infiltrating ducta R 45 NR Osteosarcoma L femur 14 M
Invasive carcinoma
with mixed lobular
and ductal featuresa L 46 Pre-menopausal Osteosarcoma R humerus 10 M
Infiltrating ducta R 51 Peri-menopausal Osteosarcoma R femur 10 F
Infiltrating carcinoma
with mixed ductal
and mucoid areasa R 54 Post-menopausal Osteosarcoma R tibia 14 M
NR=not recorded; a=special pathology review.
Table III Risk of breast cancer in mothers ofchildren with osteosarcoma and chondrosarcoma.
Breast cancer in mothers
Sub-group ofchildren
(No. ofchildren in group) Expected no. Observed no. Relative risk P
All mothers (83) 2.07 6 2.9 0.012
Mothers of boys (37) 0.90 4 4.4 0.008
Mothers of girls (46) 1.17 2 1.7 0.22
Mothers ofchildren under
median age at diagnosis (42) 0.89 4 4.5 0.008
Mothers ofchildren with
tumour of femur (41) 1.14 3 2.6 0.068
Mothers of children with
sites other than femur (42) 0.92 3 3.2 0.041
Mothers ofboys, under
median age at diagnosis,
all sites (17) 0.39 2 5.1 0.033
osteosarcoma and chondrosarcoma are at excess
risk of developing breast cancer and that this excess
risk is of a similar order to that in mothers of
children with soft tissue sarcoma, i.e. approximately
threefold. As in the group of soft tissue sarcoma
mothers, the risk is higher in mothers of boys and
in mothers of children under the median age at
diagnosis, but whereas primary site of the child's
tumour, i.e. intrapelvic, in the soft tissue sarcoma
series seemed to increase the risk in the mothers, no
association with primary site could be demonstrated
in this series.
Distribution of the histological types of breast
cancer in the mothers was unremarkable, although
it is of interest that one case had lobular car-
cinoma, a type which was found in 4 of the 8
breast cancers reported in the mothers of children
with soft tissue sarcoma.
In the soft tissue sarcoma series all 6 women with
breast cancer were pre-menopausal at time of diag-
nosis, and young compared with age at onset for
breast cancer in the general population. In this
series 4 out of 6 were probably pre-menopausal and
the remaining 2 were young compared with the
median age at onset for breast cancer in the general
population of between 60 and 64 years (North
Western Regional Health Authority, 1982). In both
groups, however, the apparent early onset of breast822 A.L. HARTLEY et al.
Table IV Other neoplasms in mothers.
Mother Child
Age at Age at
Histology Site diagnosis Histology Site diagnosis Sex
Invasive malignant melanoma with
adjacent in situ component of
superficial spreading typea R thigh 31 Chondrosarcoma R humerus 14 F
Unbiopsied pancreas 54 Osteosarcoma R humerus 6 F
Mucinous adenocarcinomaa caecum 57 Osteosarcoma R femur 9 F
Mucinous adenocarcinomaa stomach 61 Osteosarcoma R femur 14 M
Small cell anaplastic carcinomaa lung 62 Osteosarcoma L femur 13 F
Meningioma falx 68 Osteosarcoma R femur 14 F
cerebri
aSpecial pathology review.
cancer may simply reflect the age structure of the
populations under study.
The observations of an excess risk of breast
cancer in these mothers does not necessarily imply
an inherited predisposition, and the possibility of
exposure to common environmental factors within
families must be considered.
Preliminary results for the fathers of this same
group of children show that 6 are so far known to
have developed malignancies. While this number is
not above expectation, there are indications of
possible paternal inheritance of predisposition to
cancer, in that one father had a glioblastoma
multiforme, which is compatible with the pattern
seen in the Li-Fraumeni syndrome, and another a
double primary tumour, oat cell carcinoma of the
lung and a renal cell carcinoma.
In the children themselves there are clear indica-
tions of a substantial genetic component in the
aetiology for this group of tumours. In two
children their osteosarcomas developed as second
primary tumours. One child had previous bilateral
retinoblastoma, an association well recognized, and
the daughter of the mother who developed breast
cancer at age 27 years, herself had a double pri-
mary tumour, her osteosarcoma developing in the
radiation field of treatment for a medulloblastoma.
The latter observation illustrates the interaction
with environmental factors which may be necessary
for the expression of inherited genetic susceptibility
to cancer in certain individuals. A third child
survived 10 years after radiotherapy and amputa-
tion for an osteosarcoma of the right humerus, but
has recently died from a second osteosarcoma
which is sufficiently different in histological ap-
pearance to be regarded as a second primary.
The child who had two separate osteosarcomas
in the fibula and ulna had also had a fibrosarcoma
of the skull which developed in the radiation field
of treatment for an haemangioma. His identical
twin brother has developed a liposarcoma at age 39
years and the son of this individual died of a
nasopharyngeal rhabdomyosarcoma age 2 years.
Other malignancies developing in siblings of chil-
dren with osteosarcoma include malignant mel-
anoma of the cheek at age 36 years in the sister of
the child whose mother died of cancer of the
stomach. This is of interest in that one of the
mothers in the series also had a malignant mel-
anoma (Table IV). The occurrence of malignant
melanoma as part of a cancer family syndrome has
been described by Lynch et al. (1975).
Further pedigree studies are now in progress to
ascertain the incidence of malignancies in first and
second degree relatives of the children in this series,
in order to determine their relative risks of develop-
ing cancer. In this way it is hoped to provide
further clarification of patterns of inheritance of
susceptibility to cancer in these families, thus es-
tablishing a more reliable basis for genetic counsel-
ling and for screening of susceptible individuals
within the families.
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